Dawn Swan

17PUBLICATIONS
20CO-AUTHORS
Molecular targetsClinical pharmacy and pharmacy practiceRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 29, 2026
Toxicity Under-Reporting in Early-Phase Plasma Cell Dyscrasia Clinical Trial Abstracts.

|Jan 02, 2026
In a nutshell: Testing DOAC levels-when, why and what it means?

Dawn Swan, Lara Roberts, Jecko Thachil

|Nov 03, 2025
Myeloma bone disease: A constant problem in the changing landscape of myeloma management.

D Swan, A Yong, K Vandyke

|Nov 26, 2024
CAR-T cell therapy in Multiple Myeloma: current status and future challenges.

Dawn Swan, Deepu Madduri, Jay Hocking

|Aug 15, 2023
Venous thromboembolism in multiple myeloma: Increasing evidence in support of direct oral anticoagulants.

D Swan, C Comerford, J Quinn

|Apr 13, 2023
Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity.

Alessandro Natoni, Marina Cerreto, Maria Stefania De Propris

Pageof 3

Frequent Collaborators

1 joint publications

E Elhassadi

1 joint publications

C Comerford

1 joint publications

Francesco Rodeghiero

1 joint publications

Ton Lisman